Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
19.34
-0.42 (-2.13%)
Sep 11, 2026, 3:04 PM CST

SHE:002287 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,2182,4152,3362,0402,0401,766
Other Revenue
0.950.932.195.554.634.06
2,2192,4162,3382,0452,0451,770
Revenue Growth
-11.36%3.34%14.32%0.02%15.49%19.22%
Cost of Revenue
382.26410.66419.55324.7325.52269.7
Gross Profit
1,8372,0051,9181,7201,7191,501
Selling, General & Admin
1,1411,2851,2801,1621,107986.35
Research & Development
81.8281.0366.7358.6355.0970.82
Other Operating Expenses
77.2736.0934.7632.2629.4728.58
Operating Expenses
1,3001,4011,3821,2531,1921,084
Operating Income
536.21603.98536.7467.52527.71416.45
Interest Expense
-16.3-41.86-57.79-63.07-56.42-53.43
Interest & Investment Income
8.828.54.1941.9216.96340.33
Currency Exchange Gain (Loss)
1.27-0.12-0.01-0.03-0.02-0.02
Other Non Operating Income (Expenses)
16.8-1.04-0.02-1.16-3.56-2.46
EBT Excluding Unusual Items
546.8569.47483.08445.19484.68700.88
Impairment of Goodwill
------15.77
Gain (Loss) on Sale of Investments
56.8166.37100.3237.07-37.0820.69
Gain (Loss) on Sale of Assets
6.727.38-0.320-0.07
Asset Writedown
-00.06-0.58-0.3-1.22-0.35
Other Unusual Items
141.496.5763.43162.1472.8282.54
Pretax Income
751.73739.84646.24644.41519.2787.91
Income Tax Expense
93.5792.3764.8765.2449.5677.09
Earnings From Continuing Operations
658.16647.47581.37579.18469.64710.83
Minority Interest in Earnings
3.160.950.912.022.95.05
Net Income
661.33648.43582.28581.2472.54715.88
Net Income to Common
661.33648.43582.28581.2472.54715.88
Net Income Growth
7.53%11.36%0.19%22.99%-33.99%77.21%
Shares Outstanding (Basic)
561544530530530529
Shares Outstanding (Diluted)
561544530530530529
Shares Change
5.85%2.50%0.03%-0.05%0.21%0.12%
EPS (Basic)
1.181.191.101.100.891.35
EPS (Diluted)
1.181.191.101.100.891.35
EPS Growth
1.59%8.64%0.15%23.05%-34.13%77.01%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
318.83576.63201.31458.5913.29909.35
Free Cash Flow Per Share
0.571.060.380.860.031.72
Dividend Per Share
0.4200.4100.3800.4800.3900.590
Dividend Growth
-30.00%7.90%-20.83%23.08%-33.90%73.53%
Gross Margin
82.77%83.00%82.06%84.12%84.08%84.77%
Operating Margin
24.16%25.00%22.96%22.86%25.81%23.52%
Profit Margin
29.80%26.84%24.91%28.42%23.11%40.43%
Free Cash Flow Margin
14.37%23.87%8.61%22.42%0.65%51.36%
EBITDA
671.73739.51664.94552.96604.13476.77
EBITDA Margin
30.27%30.61%28.44%27.04%29.54%26.93%
D&A For EBITDA
135.52135.53128.2385.4376.4260.32
EBIT
536.21603.98536.7467.52527.71416.45
EBIT Margin
24.16%25.00%22.96%22.86%25.81%23.52%
Effective Tax Rate
12.45%12.48%10.04%10.12%9.54%9.78%
Revenue as Reported
2,2192,4162,3382,0452,0451,770